Healthcare Companies Focusing on Liver DiseasesU.S. Exchanges
List of Publicly Traded Healthcare Companies Focusing on Liver Diseases Listed on Major U.S. Exchanges
The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products relating to the liver. It is very common for companies on this list to provide products and services in other healthcare areas in addition to providing products and treatments for the liver.
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Liver: Mid-Cap Stocks
Intercept Pharmaceuticals, Inc. (ICPT) (Biopharmaceutical company: orphan and more prevalent liver diseases)
Liver: Small-Cap Stocks
Assembly Biosciences, Inc. (ASMB) (Biopharmaceutical company: treatments for hepatitis B virus infection and C. difficile-associated diarrhea)
Enanta Pharmaceuticals, Inc. (ENTA) (Small molecule drugs for viral infections and liver diseases)
FibroGen, Inc. (FGEN) (Biopharmaceutical company: anemia in chronic kidney disease, liver fibrosis, pancreatic cancer, corneal blindness)
Liver: Micro-Cap Stocks
Albireo Pharma, Inc. (ALBO) (orphan pediatric liver diseases and GI disorders)
Arbutus Biopharma Corporation (ABUS) (Canada, biopharmaceutical company: chronic hepatitis B infection)
Arrowhead Research Corporation (ARWR) (Biopharmaceutical company: RNAi therapeutics, chronic hepatitis B infection)
Conatus Pharmaceuticals Inc. (CNAT) (Medicines to treat liver disease)
Dicerna Pharmaceuticals, Inc. (DRNA) (Biopharmaceutical company: inherited diseases of the liver and genetically defined cancers)
Galmed Pharmaceuticals Ltd. (GLMD) (Israel, biopharmaceutical company: oral therapy for treating liver diseases and cholesterol gallstones)
Madrigal Pharmaceuticals, Inc. (MDGL) (Cardiovascular, liver and metabolic diseases)
Vital Therapies, Inc. (VTL) (Cell-based system for the treatment of acute liver failure)
Liver: Nano-Cap Stocks
Biostar Pharmaceuticals, Inc. (BSPM) (China: manufacturer of pharmaceutical and health supplement products; over-the-counter medicine for chronic hepatitis B)
Phaserx, Inc. (PZRX) (IPO May, 18 2016: biopharmaceutical company focused on treatments for enzyme deficiencies in the liver)